United States · FDA National Drug Code directory
Octreotide Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-896_1a5d8576-7695-42f0-871a-d8de8c7b0220
- Product NDC
- 68462-896
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Octreotide Acetate
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230809
- Source listing expiry
- 20271231
Source-listed ingredients
- OCTREOTIDE ACETATE — 100 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (68462-896-10) / 1 mL in 1 VIAL (68462-896-01) · 68462-896-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →